4-(1-hydroxy-1-methyl-ethyl)furan-2-sulfonamide|CAS 210827-34-2|DC Chemicals

Cas No.:	210827-34-2
Chemical Name:	4-(1-hydroxy-1-methyl-ethyl)furan-2-sulfonamide
Synonyms:	4-(2-hydroxypropan-2-yl)furan-2-sulfonamide;2-Furansulfonamide, 4-(1-hydroxy-1-methylethyl)-;4-(1-Methyl-1-hydroxyethyl)furan-2-sulfonamide;4-(1-hydroxy-1-methyl-ethyl)furan-2-sulfonamide;DTXSID20436448;SCHEMBL6869002;4-(1-Hydroxy-1-methylethyl)-2-furansulfonamide;210827-34-2;AS-67625;CS-0119750;AKOS037646253;A12262;EN300-216933;DB-183736;MFCD27937061;KIA82734;823-898-3;AC-37752
SMILES:	S(C1=CC(=CO1)C(C)(C)O)(N)(=O)=O
Formula:	C₇H₁₁NO₄S
M.Wt:	205.23
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC67845	N-Me-Thalidomide 4-fluoride	N-Me-Thalidomide 4-fluoride is a ligand for E3 ligase, used for the synthesis of Anti-inflammatory agent 70 .
DC67844	CRBN ligand-880	CRBN ligand-880 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein. CRBN ligand-880 can be linked to a target protein ligand via a linker to form a PROTAC.
DC67843	6-hydroxy-1-isopropyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid
DC67842	Tert-butyl 4-(4-aMino-3-Methoxyphenyl)piperazine-1-carboxylate
DC67841	Boc-NH-PEG4	Boc-NH-PEG4 (PROTAC Linker 12) is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.
DC67840	tert-Butyl (6-hydroxyhexyl)carbamate	tert-Butyl (6-hydroxyhexyl)carbamate is a PROTAC linker that can be used in the synthesis of PROTACs.
DC67839	tert-Butyl N-(2,6-dioxopiperidin-3-yl)carbamate (Standard)	tert-Butyl N-(2,6-dioxopiperidin-3-yl)carbamate (Standard) is the analytical standard of tert-Butyl N-(2,6-dioxopiperidin-3-yl)carbamate. This product is intended for research and analytical applications.
DC67838	3-amino-1-methylpiperidine-2,6-dione hydrochloride
DC67837	(S)-3-Amino-piperidine-2,6-dione hydrochloride
DC67836	(R)-3-Aminopyrrolidine-2,5-dione	(R)-3-Aminopyrrolidine-2,5-dione is a potential anticonvulsant agent and its derivatives have comparable in vivo efficacy.